BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 9312232)

  • 1. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
    Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
    Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
    [No Abstract]   [Full Text] [Related]  

  • 2. Human T-lymphotropic virus type II seroprevalence among emergency department and clinic patients.
    Agranoff D; Varney K; Khayam-Bashi H; Murphy EL
    West J Med; 1996 Jun; 164(6):481-5. PubMed ID: 8764621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of HTLV-I/II in blood donors in Monterrey, Mexico.
    Trejo-Avila LM; Fuentes-Pensamiento R; Scorro Flores-Castañeda M; Diaz-Mendoza ML; Zapata-Benavides P; Tamez-Guerra RS
    Arch Med Res; 1996; 27(1):97-9. PubMed ID: 8867376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transfusional human retrovirus infection in 41 Italian beta-thalassemic patients.
    Aglianò AM; Vania A; Gandini O; Gradilone A; Napolitano M; Albonici L; Falconieri P; Digilio G; Manzari V; Frati L
    Haematologica; 1992; 77(1):54-9. PubMed ID: 1398283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTLV-I and HIV-I antibody frequency in thalassemics and drug addicts in southeast Sicily.
    Gulisano G; Ciccia M; Ienna M; Cipolla A; Mauro L
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):531-4. PubMed ID: 1670058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low seroprevalence of HTLV-I and HTLV-II in patients with a sexually transmitted disease. Study Group for HTLV and STDs.
    Suligoi B; Galli C; Ciuta S; Decker R
    Eur J Epidemiol; 1999 Mar; 15(3):225-9. PubMed ID: 10395051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Search for antibodies against human T-cell lymphotropic virus type I (HTLV-I) in blood donors and risk groups].
    Silva Cabrera E; Pérez Guevara MT; Lubián Caballero AL; de la Fuente Arzola JL; Navea Leyva L; Cruz Sui O
    Rev Cubana Med Trop; 1997; 49(1):24-7. PubMed ID: 9685956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of antibodies to human T-lymphotropic virus-I/II among blood donors in eastern Saudi Arabia.
    Fawaz NA; Tamim H; Almawi WY
    Am J Infect Control; 2005 Apr; 33(3):189-91. PubMed ID: 15798675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-I/II seroprevalence in The Gambia: a study of mother-child pairs.
    Del Mistro A; Chotard J; Hall AJ; Fortuin M; Whittle H; De Rossi A; Chieco-Bianchi L
    AIDS Res Hum Retroviruses; 1994 May; 10(5):617-20. PubMed ID: 7917523
    [No Abstract]   [Full Text] [Related]  

  • 11. Absence of HTLV-I infection in patients with malignancy in the Yucatan peninsula.
    Góngora-Biachi RA; González-Martínez P; Puerto FI; Bastarrachea-Ortíz J; Yamaguchi K; Nishimura Y; Takatsuki K
    Rev Invest Clin; 1993; 45(3):281-2. PubMed ID: 8210771
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
    Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S
    Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A seroepidemiological survey of HTLV-I/HTLV-II in selected Belgian populations.
    Vranckx R; Coenjaert A; Muylle L
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):827-30. PubMed ID: 2390333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic virus (HTLV) types I and II: seroprevalence among intravenous drug users in continental France. Retrovirus Study Group of the French Society of Blood Transfusion.
    Coste J; Lemaire JM; Couroucé AM; Canavaggio M
    AIDS; 1993 Mar; 7(3):440-1. PubMed ID: 8097098
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of HTLV-I/II infection in blood donors in Buenos Aires.
    Gutfraind Z; Blejer JL; Saguier MC; Gómez Carretero ML; Pirola DA; Carreras Vescio LA
    Medicina (B Aires); 1995; 55(4):295-9. PubMed ID: 8728867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with human immunodeficiency viruses and human T-cell lymphotropic viruses in the same individuals in Nigeria.
    Olaleye OD; Ekweozor CC
    Rev Roum Virol; 1993; 44(3-4):233-6. PubMed ID: 7826875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
    N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.